Interleukin‐23 (IL‐23) is a heterodimeric cytokine…
onlinelibrary.wiley.com
A randomised phase II study evaluating the efficacy and safety of subcutaneously administered ustekinumab and guselkumab in patients with active rheumatoid arthritis despite treatment with methotrexate
ard.bmj.com